Imunon, Inc. (IMNN)
NASDAQ: IMNN · Real-Time Price · USD
0.812
+0.119 (17.17%)
At close: Nov 22, 2024, 4:00 PM
0.800
-0.012 (-1.47%)
After-hours: Nov 22, 2024, 6:46 PM EST
Imunon Employees
Imunon had 33 employees as of December 31, 2023. The number of employees increased by 2 or 6.45% compared to the previous year.
Employees
33
Change (1Y)
2
Growth (1Y)
6.45%
Revenue / Employee
n/a
Profits / Employee
-$589,429
Market Cap
11.77M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
China Jo-Jo Drugstores | 1,003 |
Trinity Biotech | 380 |
PAVmed | 107 |
Lyra Therapeutics | 88 |
Turnstone Biologics | 80 |
Aspira Women's Health | 64 |
Talphera | 15 |
Immuron | 7 |
IMNN News
- 16 days ago - Imunon, Inc. (IMNN) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 16 days ago - IMUNON Presents Positive Data from Phase 2 OVATION 2 Clinical Trial of IMNN-001 in Advanced Ovarian Cancer at SITC 39th Annual Meeting - GlobeNewsWire
- 16 days ago - IMUNON Reports Third Quarter 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 23 days ago - IMUNON to Hold Third Quarter 2024 Financial Results and Business Update Conference Call on Thursday, November 7, 2024 - GlobeNewsWire
- 24 days ago - IMUNON to Present Phase 2 Data of IMNN-001 in Treatment of Newly Diagnosed Ovarian Cancer at SITC 39th Annual Meeting - GlobeNewsWire
- 6 weeks ago - IMUNON Reports Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - UPDATE - IMUNON's Ovarian Cancer R&D Day to Feature Presentations from IMNN-001 Clinical Study Investigators, Immunology and Biostatistics Experts, and Executive Management - GlobeNewsWire
- 3 months ago - IMUNON to Host R&D Day on September 18th - GlobeNewsWire